Ribosomal Alterations Contribute to Bacterial Resistance against the Dipeptide Antibiotic TAN 1057

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 2, 2004, Pages 619-622

  Limburg, E ^a   Gahlmann, R ^a   Kroll, H P ^a   Beyer, D ^a,b  

^a BAYER PHARMA AG   (Germany)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DIPEPTIDE; ERYTHROMYCIN; ETHIDIUM BROMIDE; FOSFOMYCIN; FUSIDIC ACID; KANAMYCIN; LINEZOLID; METICILLIN; MOXIFLOXACIN; NEOMYCIN; PENICILLIN G; STREPTOMYCIN; TAN 1057; TAN 1057A; TAN 1057B; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ESCHERICHIA COLI; GENETICS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; RNA TRANSLATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DIPEPTIDES; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PROTEIN BIOSYNTHESIS; RIBOSOMES; STAPHYLOCOCCUS AUREUS;

EID: 0942290554     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.2.619-622.2004     Document Type: Article

References (25)

1. Aguilar, N., and J. Krüger. 2002. Towards a library synthesis of the natural dipeptide antibiotic TAN 1057 A,B. Molecules 7:469-474.
2. Berger-Bachi, B. 2002. Resistance mechanisms of gram-positive bacteria. Int. J. Med. Microbiol. 292:27-35.
3. Boeddeker, N., G. Bahador, C. Gibbs, E. Mabery, J. Wolf, L. Xu, and J. Watson. 2002. Characterization of a novel antibacterial agent that inhibits bacterial translation. RNA 8:1120-1128.
4. Brands, M., R. Endermann, R. Gablmann, J. Kruger, and S. Raddatz. 2003. Dihydropyrimidinones-a new class of anti-staphylococcal antibiotics. Bioorg. Med. Chem. Lett. 13:241-245.
5. Brands, M., R. Endermann, R. Gahlmann, J. Kruger, S. Raddatz, J. Stoltefuss, V. N. Belov, S. Nizamov, V. V. Sokolov, and A. de Meijere. 2002. Novel antibiotics for the treatment of gram-positive bacterial infections. J. Med. Chem. 45:4246-4253.
6. Champney, W. S. 2001. Bacterial ribosomal subunit synthesis: a novel antibiotic target. Curr. Drug Targets Infect. Disord. 1:19-36.
7. Champney, W. S., J. Pelt, and C. L. Tober. 2001. TAN-1057A: a translational inhibitor with a specific inhibitory effect on 50S ribosomal subunit formation. Curr. Microbiol. 43:340-345.
8. Fournier, B., Q. C. Truong-Bolduc, X. Zhang, and D. C. Hooper. 2001. A mutation in the 5′ untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J. Bacteriol. 183:2367-2371.
9. Funabashi, Y., S. Tsubotani, K. Koyama, N. Katayama, and S. Harada. 1993. A new anti-MRSA dipeptide, TAN-1057 A. Tetrahedron 49:13-28.
10. Hideo, O. March 1994. Antibiotics TAN-1057 patent EP 339596.
11. Hooper, D. C. 2001. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis. 32(Suppl. 1):S9-S15.
12. Katayama, N., S. Fukusumi, Y. Funabasbi, T. Iwabi, and H. Ono. 1993. TAN-1057 A-D, new antibiotics with potent multibacterial activity against methicillin-resistant Staphylococcus aureus. Taxonomy, fermentation and biological activity. J. Antibiot. (Tokyo) 46:606-613.
13. Kim, M. J., H. J. Yun, J. W. Kang, S. Kim, J. H. Kwak, and E. C. Choi. 2003. In vitro development of resistance to a novel fluoroquinolone. DW286, in methicillin-resistant Staphylococcus aureus clinical isolates. J. Antimicrob. Chemother. 51:1011-1016.
14. Lin, P. S., and A. Ganesan. 2000. Assembly of the TAN-1057 A/B heterocycle from a dehydroalanine precursor. Synthesis 14:2127-2130.
15. Livermore, D. M. 2003. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36:S11-S23.
16. Muller, M., and G. Blobel. 1984. In vitro translocation of bacterial proteins across the plasma membrane of Escherichia coli. Proc. Natl. Acad. Sci. USA 81:7421-7425.
17. Murray, R. W., E. P. Melchior, J. C. Hagadorn, and K. R. Marotti. 2001. Staphylococcus aureus cell extract transcription-translation assay: firefly luciferase reporter system for evaluating protein translation inhibitors. Antimicrob. Agents Chemother. 45:1900-1904.
18. Murray, R. W., R. D. Schaadt, G. E. Zurenko, and K. R. Marotti. 1998. Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay. Antimicrob. Agents Chemother. 42:947-950.
19. Ng, E. Y. W., M. Trucksis, and D. C. Hooper. 1994. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 38:1345-1355.
20. Prystowsky, J., F. Siddiqui, J. Chosay, D. L. Shinabarger, J. Millichap, L. R. Peterson, and G. A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45:2154-2156.
21. Sokolov, V. V., S. I. Kozhushkov, S. Nikolskaya, V. N. Belov, M. EsSayed, and A. deMeijere. 1998. Total synthesis of TAN-1057 A/B, a new dipeptide antibiotic from Flexibacter sp. PK-74. Eur. J. Org. Chem. 777-783.
22. Williams, R. M., C. Yuan, V. J. Lee, and S. Chamberland. 1998. Synthesis and antimicrobial evaluation of TAN-1057A/B analogs. J. Antibiot. (Tokyo) 51:189-201.
23. Wood, M. J., and R. C. Moellering, Jr. 2003. Microbial resistance: bacteria and more. Clin. Infect. Dis. 36:S2-S3.
24. Xiong, L., P. Kloss, S. Douthwaite, N. M. Andersen, S. Swaney, D. L. Shinabarger, and A. S. Mankin. 2000. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J. Bacteriol. 182:5325-5331.
25. Yuan, C. G., and R. M. Williams. 1997. Total synthesis of the anti-methicillin-resistant Staphylococcus aureus peptide antibiotics TAN-1057A-D. J. Am. Chem. Soc. 119:11777-11784.